Outer domain of HIV-1 gp120

Antigenic optimization, structural malleability, and crystal structure with antibody VRC-PG04

M. Gordon Joyce, Masaru Kanekiyo, Ling Xu, Christian Biertümpfel, Jeffrey C. Boyington, Stephanie Moquin, Wei Shi, Xueling Wu, Yongping Yang, Zhi Yong Yang, Baoshan Zhang, Anqi Zheng, Tongqing Zhou, Jiang Zhu, John R. Mascola, Peter D. Kwong, Gary J. Nabel

Research output: Contribution to journalArticle

Abstract

The outer domain of the HIV-1 gp120 envelope glycoprotein contains the epitope for broadly neutralizing antibodies directed to the CD4-binding site, many of which are able to neutralize over 90% of circulating HIV-1 isolates. While the outer domain is conformationally more stable than other portions of the HIV-1 envelope, efforts to express the outer domain as an immunogen for eliciting broadly neutralizing antibodies have not been successful, potentially because natural outer domain variants do not bind strongly to antibodies such as VRC01. In this study, we optimized the antigenic properties of the HIV-1 Env outer domain to generate OD4.2.2, from the KER2018 strain of clade A HIV-1, enabling it to bind antibodies such as VRC01 with nanomolar affinity. The crystal structure of OD4.2.2 in complex with VRC-PG04 was solved at 3.0-Å resolution and compared to known crystal structures including (i) the structure of core gp120 bound by VRC-PG04 and (ii) a circularly permutated version of the outer domain in complex with antibody PGT128. Much of the VRC-PG04 epitope was preserved in the OD4.2.2 structure, though with altered N and C termini conformations. Overall, roughly one-third of the outer domain structure appeared to be fixed in conformation, independent of alterations in termini, clade, or ligand, while other portions of the outer domain displayed substantial structural malleability. The crystal structure of OD4.2.2 with VRC-PG04 provides atomic-level details for an HIV-1 domain recognized by broadly neutralizing antibodies and insights relevant to the rational design of an immunogen that could elicit such antibodies by vaccination.

Original languageEnglish (US)
Pages (from-to)2294-2306
Number of pages13
JournalJournal of Virology
Volume87
Issue number4
DOIs
StatePublished - Feb 2013
Externally publishedYes

Fingerprint

crystal structure
Human immunodeficiency virus 1
HIV-1
antibodies
Antibodies
Neutralizing Antibodies
neutralizing antibodies
epitopes
Epitopes
HIV Envelope Protein gp120
antigens
glycoproteins
binding sites
Vaccination
Binding Sites
vaccination
Ligands

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Joyce, M. G., Kanekiyo, M., Xu, L., Biertümpfel, C., Boyington, J. C., Moquin, S., ... Nabel, G. J. (2013). Outer domain of HIV-1 gp120: Antigenic optimization, structural malleability, and crystal structure with antibody VRC-PG04. Journal of Virology, 87(4), 2294-2306. https://doi.org/10.1128/JVI.02717-12

Outer domain of HIV-1 gp120 : Antigenic optimization, structural malleability, and crystal structure with antibody VRC-PG04. / Joyce, M. Gordon; Kanekiyo, Masaru; Xu, Ling; Biertümpfel, Christian; Boyington, Jeffrey C.; Moquin, Stephanie; Shi, Wei; Wu, Xueling; Yang, Yongping; Yang, Zhi Yong; Zhang, Baoshan; Zheng, Anqi; Zhou, Tongqing; Zhu, Jiang; Mascola, John R.; Kwong, Peter D.; Nabel, Gary J.

In: Journal of Virology, Vol. 87, No. 4, 02.2013, p. 2294-2306.

Research output: Contribution to journalArticle

Joyce, MG, Kanekiyo, M, Xu, L, Biertümpfel, C, Boyington, JC, Moquin, S, Shi, W, Wu, X, Yang, Y, Yang, ZY, Zhang, B, Zheng, A, Zhou, T, Zhu, J, Mascola, JR, Kwong, PD & Nabel, GJ 2013, 'Outer domain of HIV-1 gp120: Antigenic optimization, structural malleability, and crystal structure with antibody VRC-PG04', Journal of Virology, vol. 87, no. 4, pp. 2294-2306. https://doi.org/10.1128/JVI.02717-12
Joyce, M. Gordon ; Kanekiyo, Masaru ; Xu, Ling ; Biertümpfel, Christian ; Boyington, Jeffrey C. ; Moquin, Stephanie ; Shi, Wei ; Wu, Xueling ; Yang, Yongping ; Yang, Zhi Yong ; Zhang, Baoshan ; Zheng, Anqi ; Zhou, Tongqing ; Zhu, Jiang ; Mascola, John R. ; Kwong, Peter D. ; Nabel, Gary J. / Outer domain of HIV-1 gp120 : Antigenic optimization, structural malleability, and crystal structure with antibody VRC-PG04. In: Journal of Virology. 2013 ; Vol. 87, No. 4. pp. 2294-2306.
@article{4d410b5982cc4e25acd38352de6427d7,
title = "Outer domain of HIV-1 gp120: Antigenic optimization, structural malleability, and crystal structure with antibody VRC-PG04",
abstract = "The outer domain of the HIV-1 gp120 envelope glycoprotein contains the epitope for broadly neutralizing antibodies directed to the CD4-binding site, many of which are able to neutralize over 90{\%} of circulating HIV-1 isolates. While the outer domain is conformationally more stable than other portions of the HIV-1 envelope, efforts to express the outer domain as an immunogen for eliciting broadly neutralizing antibodies have not been successful, potentially because natural outer domain variants do not bind strongly to antibodies such as VRC01. In this study, we optimized the antigenic properties of the HIV-1 Env outer domain to generate OD4.2.2, from the KER2018 strain of clade A HIV-1, enabling it to bind antibodies such as VRC01 with nanomolar affinity. The crystal structure of OD4.2.2 in complex with VRC-PG04 was solved at 3.0-{\AA} resolution and compared to known crystal structures including (i) the structure of core gp120 bound by VRC-PG04 and (ii) a circularly permutated version of the outer domain in complex with antibody PGT128. Much of the VRC-PG04 epitope was preserved in the OD4.2.2 structure, though with altered N and C termini conformations. Overall, roughly one-third of the outer domain structure appeared to be fixed in conformation, independent of alterations in termini, clade, or ligand, while other portions of the outer domain displayed substantial structural malleability. The crystal structure of OD4.2.2 with VRC-PG04 provides atomic-level details for an HIV-1 domain recognized by broadly neutralizing antibodies and insights relevant to the rational design of an immunogen that could elicit such antibodies by vaccination.",
author = "Joyce, {M. Gordon} and Masaru Kanekiyo and Ling Xu and Christian Biert{\"u}mpfel and Boyington, {Jeffrey C.} and Stephanie Moquin and Wei Shi and Xueling Wu and Yongping Yang and Yang, {Zhi Yong} and Baoshan Zhang and Anqi Zheng and Tongqing Zhou and Jiang Zhu and Mascola, {John R.} and Kwong, {Peter D.} and Nabel, {Gary J.}",
year = "2013",
month = "2",
doi = "10.1128/JVI.02717-12",
language = "English (US)",
volume = "87",
pages = "2294--2306",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Outer domain of HIV-1 gp120

T2 - Antigenic optimization, structural malleability, and crystal structure with antibody VRC-PG04

AU - Joyce, M. Gordon

AU - Kanekiyo, Masaru

AU - Xu, Ling

AU - Biertümpfel, Christian

AU - Boyington, Jeffrey C.

AU - Moquin, Stephanie

AU - Shi, Wei

AU - Wu, Xueling

AU - Yang, Yongping

AU - Yang, Zhi Yong

AU - Zhang, Baoshan

AU - Zheng, Anqi

AU - Zhou, Tongqing

AU - Zhu, Jiang

AU - Mascola, John R.

AU - Kwong, Peter D.

AU - Nabel, Gary J.

PY - 2013/2

Y1 - 2013/2

N2 - The outer domain of the HIV-1 gp120 envelope glycoprotein contains the epitope for broadly neutralizing antibodies directed to the CD4-binding site, many of which are able to neutralize over 90% of circulating HIV-1 isolates. While the outer domain is conformationally more stable than other portions of the HIV-1 envelope, efforts to express the outer domain as an immunogen for eliciting broadly neutralizing antibodies have not been successful, potentially because natural outer domain variants do not bind strongly to antibodies such as VRC01. In this study, we optimized the antigenic properties of the HIV-1 Env outer domain to generate OD4.2.2, from the KER2018 strain of clade A HIV-1, enabling it to bind antibodies such as VRC01 with nanomolar affinity. The crystal structure of OD4.2.2 in complex with VRC-PG04 was solved at 3.0-Å resolution and compared to known crystal structures including (i) the structure of core gp120 bound by VRC-PG04 and (ii) a circularly permutated version of the outer domain in complex with antibody PGT128. Much of the VRC-PG04 epitope was preserved in the OD4.2.2 structure, though with altered N and C termini conformations. Overall, roughly one-third of the outer domain structure appeared to be fixed in conformation, independent of alterations in termini, clade, or ligand, while other portions of the outer domain displayed substantial structural malleability. The crystal structure of OD4.2.2 with VRC-PG04 provides atomic-level details for an HIV-1 domain recognized by broadly neutralizing antibodies and insights relevant to the rational design of an immunogen that could elicit such antibodies by vaccination.

AB - The outer domain of the HIV-1 gp120 envelope glycoprotein contains the epitope for broadly neutralizing antibodies directed to the CD4-binding site, many of which are able to neutralize over 90% of circulating HIV-1 isolates. While the outer domain is conformationally more stable than other portions of the HIV-1 envelope, efforts to express the outer domain as an immunogen for eliciting broadly neutralizing antibodies have not been successful, potentially because natural outer domain variants do not bind strongly to antibodies such as VRC01. In this study, we optimized the antigenic properties of the HIV-1 Env outer domain to generate OD4.2.2, from the KER2018 strain of clade A HIV-1, enabling it to bind antibodies such as VRC01 with nanomolar affinity. The crystal structure of OD4.2.2 in complex with VRC-PG04 was solved at 3.0-Å resolution and compared to known crystal structures including (i) the structure of core gp120 bound by VRC-PG04 and (ii) a circularly permutated version of the outer domain in complex with antibody PGT128. Much of the VRC-PG04 epitope was preserved in the OD4.2.2 structure, though with altered N and C termini conformations. Overall, roughly one-third of the outer domain structure appeared to be fixed in conformation, independent of alterations in termini, clade, or ligand, while other portions of the outer domain displayed substantial structural malleability. The crystal structure of OD4.2.2 with VRC-PG04 provides atomic-level details for an HIV-1 domain recognized by broadly neutralizing antibodies and insights relevant to the rational design of an immunogen that could elicit such antibodies by vaccination.

UR - http://www.scopus.com/inward/record.url?scp=84873855312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873855312&partnerID=8YFLogxK

U2 - 10.1128/JVI.02717-12

DO - 10.1128/JVI.02717-12

M3 - Article

VL - 87

SP - 2294

EP - 2306

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 4

ER -